Our French collaborators

Outside of Paris

  • Pierre Olivier Angrand, PU, Université de Lille – 2024 –Using the zebrafish as a model for testing new treatments for liver cancer.
  • MA Boutet (Inserm UMRS 1229, Nantes) 2022 – Intra-articular Delivery of Therapeutic RNAs for Personalized Modulation of Synovial Macrophage Pathogenicity in Osteoarthritis.
  • DC Arruda (LBTI, CNRS UMR 5305, Lyon) 2021 – Design of Hybrid Particles for RNA Delivery
  • Dr J M. Taymans (University of Lille) 2021- Identification and in vitro and in vivo validation of new BBB shuttles
  • Dr. S. Loisel (University of Brest). 2017- In vivo validation of interfering peptides blocking protein/protein interactions
  • Yannis François (LSMIS, Université de Strasbourg) 2017 –Ultrafast Calorimetry for the Study of Compounds of Pharmaceutical Interest
  • P Tchoreloff, V Busignies (CNRS UMR 5295, Bordeaux) 2014 –Use of the compression process in a new approach to RNA delivery
  • S. Veesler (Centre Interdisciplinaire de Nanoscience de Marseille) 2011- co-crystals’s Solubility.
  • I. Ranchon-Colle (Clermont-Ferrand) 2015-Encapsulation of PBN in Liposomes for the Treatment of AMD
  • C Pichon, P. Midoux (CBM, Orléans) 2007 – Gene Delivery Using Lipothioureas Design of Gas Microbubbles for Gene Delivery.
  • O. Tillement, F. Lux (Univ. Lyon) 2010- Evaluation of Functionalized Gadolinium Oxides for Targeting Asialoglycoproteins
  • P. Négrier (LOMA, Bordeaux) 1998-X-ray Diffraction and Modeling
  • J-L Coll (Institut Albert Bonniot, Grenoble) 2013-Evaluation of the Permeabilization and Retention Effects in Various Tumor Models
  • M-P. Rols (IPBS, Toulouse) 2006-2011 –Mechanistic Study of Gene Transfer Induced by Triblock Copolymers

  • Paris and the Île-de-France region

    • Dr Romina Aron Badin, CEA, Paris 2024 – Validation of Therapeutic Peptides for Parkinson’s Disease
    • L Demange (UMR CNRS 8038 CITCOM, University of Paris Cité 2020-Project TARMAC Towards new treatments against Age-Related MACular degeneration
    • Dr P. Tuffery (University of Paris Cite). 2017- Identification in silico and in vitro validation of new interfering peptides blocking protein/protein interactions
    • Dr C. Z. Dong (University of Paris Cite). 2018- Biological and chemical modification of peptides.
    • Dr. H. Bruzzoni-Giovanelli (CIC Saint Louis Hospital) 2017- Identification of new protein/protein interactions involved in tumoral diseases
    • F. Ramaz (ESPCI) 2019-, Development of a New Optical Detection Method
    • B-T Doan (Chimie ParisTech), New MRI Contrast Agents
    • F. Peyrot (Université Paris Descartes, LCBPT), 2018-, Encapsulation of RPE Probes in Nanoemulsions for the In Vivo Detection of Reactive Oxygen Species
    • F. Brignole Baudoin (Institut de la Vision INSERM UMRS968-CNRS UMR7210) 2015,Gelling solutions for ocular mydriasis
    • P. De Lonlay (Hôp. Necker) & N. Seta (Hôp. Bichat) 2016,Microparticles with Controlled Release for the Treatment of Congenital Glycosylation Disorders
    • S. Auvin (Hôp. Debré – INSERM U1141) 2014- , Effervescent formulation containing pyridoxal-5-phosphate
    • P. Couvreur, D. Desmaele (Galien Institute Paris sud) 2015-, Squalene-based nanoparticles for SiRNA encapsulation
    • M. Paul (Hopital Henri Monodr, Créteil) 2015- , Liposomes co-encapsulating an anticancer agent and an antiangiogenic agent
    • R. Malafosse (Hôp. Antoine Paré) 2014- Treatment of Colon Tumors Using Radiofrequency and Immunotherapy
    • S. Gil, T. Fournier, V. Tsatsaris (UMR-S 767 Paris Descartes) 2014-,Placental passage of nanoparticles
    • F. Gazeau (Univ. Paris Diderot) 2013-, Characterization of Hybrid NPs
    • O. Clément (HEGP) 2013-, Observation and dynamics of in vivo cell homing
    • V. Vanneau (Unité de Thérapie Cellulaire, Hôpital St Louis) 2013-,Preservation and Transplantation of Myocardial Progenitor Cells
    • I. Margaill, C. Marchand-Leroux (Univ. Paris Descartes) 2013-, Stroke Diagnosis Using Stealth Iron Nanoparticles
    • C. Boisson Vidal (Univ. Paris Descartes) 2012-, Stem Cell Labeling (EPC) and In Vivo Tracking in a Mouse Model of Lower Limb Ischemia
    • G. Renault,(Institut Cochin, Paris 5) 2012- ,In Vivo Validation of Gas Microbubbles
    • M. Tanter, J-L. Gennisson, O. Couture (Institut Langevin, Paris 6) 2011- , Ultrasound elastography imaging of model colon tumors
    • Pr. B. Van Beers, R. Sinkus (Hôp. Bichat, Paris 7) 2010-,Evaluation of New Markers of Liver Function
    • J-F. Berret (Univ. Paris Diderot) 2008-,Functionalization of Stabilized USPIOs for Targeting Asialoglycoproteins
    • P. Rat (Université Paris Descartes) 2011-, Cellular Cytotoxicity of Multiple Emulsions
    • Y. Frapart, (Univ. Paris Descartes) 2009-2012 Stabilization of Paramagnetic Derivatives
    • B. Viana (Chimie Paristech) 2006-, Optical Properties of Nanoparticles
    • M.-C. Menet (UMR INSERM 705 / CNRS 8206) 2009 –, HPLC Coupling – Thermal Analysis
    • E. Gabison (Fondation Rotschild d’Ophtalmologie, Paris, France) 2017 –
    • Cell and Gene Therapies for Blinding Ocular Surface Lesions
    • Marianne Mangeney (Institut Cochin, Paris, France) 2022 –
    • Adoptive cell immunotherapy—T cells genetically modified to express a chimeric antigen receptor (CAR-T cells)
    • Pr Xavier Cachet et Thomas Gaslonde – UMR CNRS 8038- CITCOM – faculty of Pharmacy – Paris Cité University
    • Dr Sergii RUDIUK – Nanobiosciences and Microsystems – UMR8640, Department of Chemistry – Ecole Normale Supérieure
    • Dr Camille FAURE – Inserm U1016 – CNRS UMR8104 – Paris Cité university
    • Pr Bruno Crestani – Inserm UMR 1152 – APHP
    • Dr Nicaise Tuike Ndam et Rachida Tahar, UMR216 MERIT, IRD – Paris Cité University, Paris